Getting to Know Jose Gonzalez
GM at CSL Behring’s Kankakee manufacturing facility looks back on an eventful first year.
Why Diversity Matters
Diversity is good for our people, it’s good for our business and it’s good for our patients.
The Family That Curls Together
Curling takes strategy, teamwork and a quick broom, says CSL Behring’s Brian Dudt, who coached his daughter's team to a natio…
CSL’s Broad Response to COVID-19 and Advancements Across the Company’s Strategic Scientific Platforms are the Focus of Annual R&D Day
MELBOURNE, AU and KING OF PRUSSIA, PA • Vaccine, hyperimmune and monoclonal antibodies all in clinical stages as potential…
What Is It Like to Have Sickle Cell Disease?
In their own words, patients and caregivers describe the disease’s emotional toll.
Flu Shots for the Family
CSL Behring offers an outdoor flu vaccine clinic to help employees – and their loved ones – stay well this winter.
Weathering the Storm After a Heart Attack
New analysis confirms the threat of recurrent heart attacks still persists.
What is Acute Respiratory Distress Syndrome?
More research is needed to better understand ARDS, a serious lung problem getting recent attention due to COVID-19.
The Power of Big Goals
When leaders at CSL Behring set ambitious new targets, they were following in the footsteps of audaciously successful compani…
A Big Victory for Alex Dowsett
Dowsett, who has hemophilia and is an advocate for those with bleeding disorders, unexpectedly won stage 8 of the Giro d’Ital…
What Is a Phase 3 Clinical Trial?
A potential hyperimmune treatment for COVID-19 reaches a U.S. regulatory milestone designed to test for effectiveness and saf…